Entrada Therapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Entrada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Entrada Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Entrada Therapeutics by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $2.3M | 151k | 15.09 |
| 2023-09-30 | $2.5M | 155k | 15.80 |
| 2023-06-30 | $2.2M | 142k | 15.14 |
| 2023-03-31 | $1.3M | 90k | 14.50 |
| 2022-12-31 | $1.2M | 89k | 13.52 |
| 2022-09-30 | $1.4M | 88k | 15.76 |
| 2022-06-30 | $522k | 43k | 12.20 |
| 2022-03-31 | $646k | 69k | 9.40 |
| 2021-12-31 | $1.1M | 64k | 17.14 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management